$TYRA 4 SEC Filings

Filed On	Filing
17 Sep 2026	Form 4: Ra Capital MANAGEMENT, L.p., Director and 4 others Acquired 9,078,529 Pre-Funded Warrants (Right to Buy) (Open Market Purchase) ($200M)
17 Sep 2026	Form 4: Harris Todd, Director Received 864 shares as a grant or award ($7.89K)
17 Sep 2026	Form 4: Rueb Yuliya, Vice President, Finance (PAO) Received 2,925 shares as a grant or award ($26.7K)
17 Sep 2026	Form 4: Fuhrman Alan, Chief Financial Officer Received 951 shares as a grant or award ($8.68K)
11 Sep 2026	Form 4: Verjee Rehan, Director Bought 971.8943 shares ($20K)
01 Jun 2026	Form 4: Ra Capital MANAGEMENT, L.p., Director and 4 others Granted 13,160 Stock Option (Right to Buy)
01 Jun 2026	Form 4: Verjee Rehan, Director Granted 13,160 Stock Option (Right to Buy)
01 Jun 2026	Form 4: Moran Susan, Director Granted 13,160 Stock Option (Right to Buy)
01 Jun 2026	Form 4: Simson Jake, Director Granted 13,160 Stock Option (Right to Buy)
01 Jun 2026	Form 4: Gulfo Adele M., Director Granted 13,160 Stock Option (Right to Buy)
01 Jun 2026	Form 4: More Robert J, Director Granted 13,160 Stock Option (Right to Buy)
01 Jun 2026	Form 4: Rothenberg Stephen Michael, Director Granted 13,160 Stock Option (Right to Buy)
07 May 2026	Form 4: Warner Douglas J, Chief Medical Officer Received 25,000 shares as a grant or award · Granted 85,000 Stock Option (Right to Buy)
07 May 2026	Form 4: Fuhrman Alan, Chief Financial Officer Received 20,000 shares as a grant or award · Granted 67,000 Stock Option (Right to Buy)
07 May 2026	Form 4: Harris Todd, Director Received 79,000 shares as a grant or award · Granted 265,000 Stock Option (Right to Buy)
07 May 2026	Form 4: Ashar Bhavesh, Chief Operating Officer Received 15,013 shares as a grant or award · Granted 50,295 Stock Option (Right to Buy)
07 May 2026	Form 4: Rueb Yuliya, Vice President, Finance (PAO) Received 8,333 shares as a grant or award · Granted 28,000 Stock Option (Right to Buy)
20 Apr 2026	Form 4: Dable Habib J, Director Granted 44,400 Stock Option (Right to Buy)
27 Mar 2026	Form 4: Kaplan Gilla, Director Received 14,295 shares by exercise or conversion ($32.2K) · Sold 14,295 shares ($529K) · Disposed of 53,172 shares (Option Exercise/Conversion) ($120K) · 2 more
17 Mar 2026	Form 4: Fuhrman Alan, Chief Financial Officer Received 1,376 shares as a grant or award ($12.6K)

Comments